Key emerging issues in progressive supranuclear palsy and corticobasal degeneration (Q28084976)

progressive supranuclear palsy

main subject

1 reference

Keith A. Josephs

1

1 reference

language of work or name

1 reference

March 2015

1 reference

1 reference

262

1 reference

issue

3

1 reference

page(s)

783-8

1 reference

Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

Validation of the new consensus criteria for the diagnosis of corticobasal degeneration

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

Diffusion tensor imaging of Parkinson's disease, multiple system atrophy and progressive supranuclear palsy: a tract-based spatial statistics study

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

A disease-specific metabolic brain network associated with corticobasal degeneration

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

The evolution of primary progressive apraxia of speech

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

Characterization of tau oligomeric seeds in progressive supranuclear palsy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

Divergent CSF τ alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

Rate of decline in progressive supranuclear palsy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

Longitudinal quantitative MRI in multiple system atrophy and progressive supranuclear palsy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

Exome sequencing in familial corticobasal degeneration

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

Brain homogenates from human tauopathies induce tau inclusions in mouse brain

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

Intrinsic connectivity network disruption in progressive supranuclear palsy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

Criteria for the diagnosis of corticobasal degeneration

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

Functional impairment in progressive supranuclear palsy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

Rates of brain atrophy and clinical decline over 6 and 12-month intervals in PSP: determining sample size for treatment trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

Corticodentatonigral Degeneration With Neuronal Achromasia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

Functional disturbance of the locomotor network in progressive supranuclear palsy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

Pathology and sensitivity of current clinical criteria in corticobasal syndrome

2 June 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7682-Y

Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7682-Y

Diffusion tensor imaging comparison of progressive supranuclear palsy and corticobasal syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7682-Y

Imaging measures predict progression in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7682-Y

Modeling trajectories of regional volume loss in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7682-Y

FDG-PET in pathologically confirmed spontaneous 4R-tauopathy variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7682-Y

The pimple sign of progressive supranuclear palsy syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7682-Y

Pallidonigroluysian atrophy associated with p.A152T variant in MAPT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7682-Y

A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7682-Y

Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-015-7682-Y

Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372246

10.1007/S00415-015-7682-Y

27 November 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

1040985317

0 references

1 reference

1 reference

PubMed publication ID

25701010

1 reference